Arch Therapeutics Inc ARTHQ

Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.

GREY:ARTHQ - Post by User

Arch Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

(1025)
•••

Comment by Moemoney42on Oct 28, 2020 3:56pm

207 Views

Post# 31797423

RE:Today's KOL Roundtable

Moemoney42 wrote: Is a great endosement of AC5... just a matter of time before this product gets huge attention..! When that happens the stock is going to move and fast.. a penny stock with this much potential is hard to find... BUY..!!!! IMHO

Put my money where my mouth is today and bought another 20,000 shares... ;-)

<< Previous

Bullboard Posts

Next >>

Cymat to acquire value-added tech from Rio Tinto